Here, we have characterized the entire family of JmjC+N histone demethylases of
D. melanogaster, which consists of four members: dJARID1/Lid, dJARID2/CG3654, dJMJD2(1)/CG15835 and dJMJD2(2)/CG33182. JmjC-demethylases are characterized by their ability to demethylate trimethyllysine residues (
14). Our results indicate that dJARID1/Lid demethylates H3K4me3, which is in agreement with recently reported results by others (
15,
17,
23). On the other hand, dJMJD2(1)/CG15835 and dJMJD2(2)/CG33182 demethylate both H3K9me3 and H3K36me3. Our results strongly suggest that these enzymes are also capable to demethylate dimethyllysine residues, as decreased trimethylation observed when they are over-expressed is not accompanied by increased dimethylation (
Supplementary Data, Figure S3). Finally, no demethylase activity on H3K4me3, H3K9me3, H3K27me3, H3K36me3 and H4K20me3 could be attributed to dJARID2/CG3654. Interestingly, residues within the JmjC domain involved in binding Fe(II) and αKG (B, shown in red and blue, respectively) (
46), which are highly conserved in all JmjC proteins showing histone demethylase activity (
14), are present in dJARID1/Lid, dJMJD2(1)/CG15835 and dJMJD2(2)/CG33182, but not in dJARID2/CG3654. In dJARID2/CG3654, two of the three residues involved in co-ordination of Fe(II) are not conserved (B), indicating that binding of Fe(II) should be strongly perturbed. Similarly, binding of αKG is likely to be perturbed as one of the two essential JmjC domain residues involved in this interaction is not conserved (B). A similar situation is observed in mammalian JARID2, where residues involved in binding αKG and Fe(II) are not conserved either (B). Altogether, these observations suggest that the JmjC domain of JARID2 proteins might not be enzymatically active. Whether, they are capable at all of carrying out any demethylating reaction remains, however, to be determined.
dJMJD2(1)/CG15835 and dJMJD2(2)/CG33182, which demethylate both H3K9me3 and H3K36me3, are structurally homologous to mammalian JMJD2D (A). Mammalian JMJD2D, however, demethylates H3K9me3 but is not capable to demethylate H3K36me3 (
44). On the other hand, similar to the
Drosophila JMJD2 proteins, mammalian JMJD2A and JMJD2C isoforms demethylate both H3K9me3 and H3K36me3 (
44). Actually, though missing any DNA/chromatin-binding domains, the catalytic JmjC domains of CG15835 and CG33182 show slightly higher homology to those of mammalian JMJD2A-C (68–71% identity) than to that of JMJD2D (63–66% identity) (B). Recent structural studies identified residues within the JmjC domain of mammalian JMJD2A involved in binding H3K9me3 and H3K36me3 peptides (
59–61). In both cases, similar interactions help to bring the methyllysine residue close to the active site of the enzyme. However, significant differences are observed at the regions where the peptides enter and exit the JmjC domain. For the H3K36me3 peptide, these interactions involved the C-terminal region of the JmjC domain and, in particular, residues R309, K314 and S316 that, in the case of H3K9me3, are not involved in peptide binding. Interestingly, this region is conserved in the
Drosophila JMJD2 isoforms, as well as in mammalian JMJD2C, but not in mammalian JMJD2D (B).
Our results also show that, despite its ability to demethylate H3K4me3, dJARID1/Lid antagonizes silencing both of the homoeotic gene
Ubx as well as heterochromatin-dependent gene silencing. Moreover, consistent with a contribution to gene activation, dJARID1/Lid regulates acetylation of histone H3. These observations are surprising, as, on the basis of its histone demethylase activity, the opposite effects would be expected since H3K4me3 correlates with transcriptionally active genes. Actually, more in agreement with its enzymatic activity, mammalian JARID1D was reported to interact with the polycomb (PcG) protein RING6a/MBLR and to prevent access of the basal transcription machinery to the human ‘engrailed’ promoter (
16). Whether dJARID1/Lid, which is more closely related to JARID1A/B than to JARID1D (A), interacts with PcG proteins is not known. It is possible that the various JARID1 isoforms would perform different non-redundant functions. It is also possible that, depending on the actual context, dJARID1/Lid would favour transcription activation or repression. Actually, the fission yeast orthologue (SpLid2C) is a component of a multi-protein complex containing Ash2 (
62), an evolutionarily conserved TrxG protein involved both in gene activation and silencing. Interestingly, the same complex contains SpEcm5, which is also a JmjC+N protein of the JARID1 family (
62). Whether these interactions are conserved in
Drosophila, and if they contribute to the functional properties of dJARID1/Lid, remains to be determined. Finally, the overall increase on H3K4me3 that occurs in the absence of dJARID1/Lid might alter binding to chromatin of transcription activators recognizing H3K4me3. Actually, slight changes in the abundance of the chromo-helicase Chd1, which binds H3K4me3 and associates with transcriptionally active
loci, were reported at the
Sgs4 ‘locus’ in polytene chromosomes from RNAi
lid knockdown larvae (
17). At this respect, it must be noticed that the pattern of H3K4me3 of the
Ubx ‘locus’ is finely regulated (
63). In haltere/leg discs, where
Ubx is highly expressed, trimethylation of H3K4 is constrained to a relatively short region spanning the transcription start site. On the other hand, in wing discs, where
Ubx is not expressed, no significant enrichment in H3K4me3 is detected throughout the ‘locus’. Various HMTs contribute to establishment/maintenance of this pattern of H3K4me3. It is known that, in haltere/leg discs,
ash1 is required to maintain high levels of H3K4me3 at the transcription start site (
63). On the other hand,
E(z) is required to prevent H3K4 trimethylation in the wing disc (
63).
lid, which is the only H3K4me3 demethylase of
Drosophila, is likely to contribute also to establishment/maintenance of the pattern of H3K4me3 of the
Ubx gene. Further work is required to determine the precise molecular mechanisms of the contribution of dJARID1/Lid to
Ubx activation. However, it is possible that, in its absence, H3K4me3 would spread throughout the ‘locus’ altering loading/assembly of the initiation complex at the transcription start site. Actually, it was recently shown that H3K4me3 regulates binding of the general transcription factor TFIID (
64).
Here, we have also shown that dJMJD2(1)/CG15835 influences heterochromatin organization, as its over-expression induces spreading of HP1 into euchromatin. dJMJD2(1)/CG15835, however, is excluded from heterochromatin and, consistent with this observation, over-expression of dJMJD2(1)/CG15835 does not affect the pattern of H3K9me2,3 at heterochromatin. On the contrary, dJMJD2(1)/CG15835 localizes to multiple euchromatic sites, where it mostly regulates H3K36me3, as its over-expression results in a strong decrease in the levels of H3K36me3. At euchromatin, dJMJD2(1)/CG15835 also demethylates H3K9me3, but to a lesser extent. Altogether, these observations indicate that H3K36me3 acts as a barrier that prevents spreading of HP1 into euchromatin. It was shown earlier that methylation of H3K4 also prevents spreading of heterochromatin (
52). Interestingly, both H3K36 and H3K4 methylation associate to actively transcribed genes, suggesting that gene activity is a main determinant to delimit hetero- and euchromatic territories. Specific recognition of H3K9me2,3 is known to regulate binding of HP1 to chromatin (
6–9). However, spreading of HP1 observed upon over-expression of dJMJD2(1)/CG15835 is not accompanied by a parallel spreading of H3K9me2,3, indicating that it involves additional mechanisms. Actually, HP1 is also known to be capable of binding directly to DNA, RNA as well as unmodified histones (
65–67).